Log in to save to my catalogue

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects...

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82f907164cb743dda31b3eea88380ee6

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

About this item

Full title

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2017-07, Vol.17 (1), p.494-494, Article 494

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of cancer incidence of a number of solid tumours, including prostate cancer (PCa). However, the underlying biological mechanisms for these obse...

Alternative Titles

Full title

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_82f907164cb743dda31b3eea88380ee6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82f907164cb743dda31b3eea88380ee6

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-017-3458-3

How to access this item